Aptose Biosciences Inc.

13F holders, Q1 2024 (March 31)
25holders
1famous investor
$1.66avg. 13F price*

At the end of Q1 2024, 25 institutions reported holding Aptose Biosciences Inc. in their 13F filings. The largest holders were DRW Securities, LLC ($984K), Sigma Planning Corp ($309K) and Nantahala Capital Management, LLC ($147K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Aptose Biosciences Inc.
CUSIP
03835T309
Latest filing quarter
Q4 2024

History

Number of 13F holders

0510152025 Q1 2024: 25Q1 2024Q2 2024: 23Q2 2024Q3 2024: 25Q3 2024Q4 2024: 24Q4 2024

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions2$52K
Exits3$304K

Ownership 25 holders

DRW Securities, LLC 0.06% No change 592,829 $984K
Sigma Planning Corp 0.01% Add +147.0% 186,417 $309K
Nantahala Capital Management, LLC 0.01% Reduce -26.3% 88,540 $147K
Morgan Stanley 0.00% Reduce -62.1% 33,893 $56K
Citadel Advisors 0.00% Reduce -58.5% 25,691 $43K
Cetera Investment Advisers 0.00% New 21,322 $35K
Texas Capital Bank Wealth Management Services Inc 0.00% No change 12,448 $21K
PDS Planning, Inc 0.00% New 10,000 $17K
TD Waterhouse Canada Inc. 0.00% No change 7,345 $15K
US Bancorp \de 0.00% No change 2,020 $3K
Gleason Group, Inc. 0.00% No change 1,216 $2K
Royal Bank of Canada 0.00% Reduce -79.8% 1,365 $2K
NFSG Corp 0.00% No change 832 $1K
Osaic Holdings, Inc. 0.00% No change 420 $697
HighMark Wealth Management LLC 0.00% No change 300 $498
Beaird Harris Wealth Management, LLC 0.00% No change 250 $415
Northwestern Mutual Wealth Management Co. 0.00% Reduce -58.3% 133 $221
Federation des caisses Desjardins du Quebec 0.00% No change 102 $219
Group One Trading LLC 0.00% No change 115 $191
Wells Fargo & Company 0.00% Add +56.5% 72 $120
Bank of America Corp. 0.00% Reduce -34.0% 66 $110
Pacific Capital Wealth Advisors, Inc. 0.00% No change 6 $10
FIL Ltd 0.00% No change 1 $2
Citigroup Inc. 0.00% No change 1 $2
National Bank of Canada 0.00% Reduce -92.9% 1 $1

"% of holder's portfolio" is APTOSE BIOSCIENCES INC's weight in each manager's 13F, not the share of Aptose Biosciences Inc. the manager owns.